We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$184B
AUM Growth
+$19.3B
Cap. Flow
+$14.4B
Cap. Flow %
7.84%
Top 10 Hldgs %
28.75%
Holding
9,312
New
1,386
Increased
3,407
Reduced
3,196
Closed
1,107

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$657M
2
AVGO icon
Broadcom
AVGO
+$562M
3
GS icon
Goldman Sachs
GS
+$549M
4
MSFT icon
Microsoft
MSFT
+$418M
5
RTX icon
RTX Corp
RTX
+$345M

Sector Composition

Rank Sector Weight
1 Technology 5.07%
2 Financials 4.87%
3 Industrials 4.29%
4 Consumer Discretionary 3.64%
5 Healthcare 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPIX
8001
DELISTED
ESSA Pharma
EPIX
$10K ﹤0.01%
2,682
+603
+29% +$2.51K
PLX icon
8002
Protalix BioTherapeutics
PLX
$190M
$10K ﹤0.01%
+1,931
New +$12.7K
NBSE
8003
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$10K ﹤0.01%
+112
New +$16.7K
LGC.WS
8004
DELISTED
Legacy Acquisition Corp. Warrants, exercisable for one-half of one share of Class A Common Stock for
LGC.WS
$10K ﹤0.01%
29,600
+7,600
+35% +$2.85K
CRIS icon
8005
Curis
CRIS
$3.91M
$9K ﹤0.01%
7
-154
-96% -$202K
JAGX icon
8006
Jaguar Health
JAGX
$3.85M
0
JONE
8007
PUT
DELISTED
Jones Energy, Inc.
JONE
$8K ﹤0.01%
+520
New +$11.3K
ANTH
8008
CALL
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$8K ﹤0.01%
26,300
-12,000
-31% -$17.9K
GLOWE
8009
DELISTED
GLOWPOINT INC
GLOWE
$8K ﹤0.01%
34,215
+10,676
+45% +$2.5K
PLX icon
8010
CALL
Protalix BioTherapeutics
PLX
$190M
$7K ﹤0.01%
+1,340
New +$8.82K
NLST
8011
DELISTED
Netlist, Inc.
NLST
$7K ﹤0.01%
+30,928
New +$9.29K
CXRX
8012
CALL
DELISTED
Concordia International Corp. Common Stock
CXRX
$7K ﹤0.01%
14,800
-9,300
-39% -$6.12K
PGH
8013
PUT
DELISTED
Pengrowth Energy Corporation
PGH
$7K ﹤0.01%
+11,600
New +$8.62K
NCTY
8014
The9 Ltd
NCTY
$64.9M
$6K ﹤0.01%
+44
New +$9.99K
IPCI
8015
CALL
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$6K ﹤0.01%
1,090
-340
-24% -$2.46K
PLAG icon
8016
Planet Green Holdings
PLAG
$16.1M
$5K ﹤0.01%
+103
New +$5.43K
RAS
8017
DELISTED
RAIT Financial Trust
RAS
$5K ﹤0.01%
28,906
-189,715
-87% -$69.5K
HBM.WS
8018
DELISTED
Hudbay Minerals Inc.
HBM.WS
$3K ﹤0.01%
45,492
+892
+2% +$181
RAS
8019
PUT
DELISTED
RAIT Financial Trust
RAS
$2K ﹤0.01%
11,900
-35,200
-75% -$12.9K
AB icon
8020
AllianceBernstein
AB
$3.41B
-8,060
Closed -$215K
ABCB icon
8021
Ameris Bancorp
ABCB
$6B
-25,360
Closed -$1.22M
ABEO icon
8022
PUT
Abeona Therapeutics
ABEO
$361M
-456
Closed -$181K
ABG icon
8023
PUT
Asbury Automotive
ABG
$3.78B
-4,000
Closed -$256K
ACIC icon
8024
American Coastal Insurance
ACIC
$461M
-24,895
Closed -$429K
ACLS icon
8025
CALL
Axcelis
ACLS
$4.42B
-25,400
Closed -$729K

Similar funds

Citadel Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Citadel Advisors held 9,312 positions worth $184B, up 12% from $164B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $14.4B of net new capital in Q1 2018, opening 1,386 new positions and adding to 3,407 existing holdings. Its largest new stake was Coterra Energy: 3,637,165 shares worth $87.2M.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 6.1% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Comcast, an estimated $764M trimmed.

  • Citadel Advisors's largest Q1 2018 buy was Coterra Energy: 3,637,165 shares worth $87.2M.
  • Citadel Advisors added most to NXP Semiconductors in Q1 2018, an estimated $657M increase.
  • Citadel Advisors's biggest Q1 2018 reduction was Comcast, cutting an estimated $764M.
  • Citadel Advisors fully exited MSC Industrial Direct in Q1 2018, selling an estimated $118M.
  • Citadel Advisors's ten largest holdings make up 29% of its $184B portfolio in Q1 2018.
  • Citadel Advisors opened 1,386 new positions and closed 1,107 in Q1 2018.
  • Citadel Advisors's portfolio value rose 12% quarter-over-quarter to $184B.

Based on Citadel Advisors's 13F filing for Q1 2018, filed 11 May 2018.